Part 3.2 / M13, M15

Catalogusnummer

►M18  Chemische naam ◄

EG-nr.

CAS-nr.

Indeling

Etikettering

►M18  Specifieke concentratiegrenzen, M-factoren en ATE's (*1)  ◄

Opmerkingen

Gevarenklasse en

-categorie

Gevarenaanduiding

Pictogram, signaalwoord

Gevarenaanduiding

Aanvullende gevarenaanduiding

▼M16

005-020-00-3

dinatriumoctaboraat watervrij; [1]

dinatriumoctaboraat tetrahydraat [2]

234-541-0 [1]

234-541-0 [2]

12008-41-2 [1]

12280-03-4 [2]

Repr. 1B

H360FD

GHS08

Dgr

H360FD

006-035-00-8

pirimicarb (ISO); 2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamaat

245-430-1

23103-98-2

Carc. 2

Acute Tox. 3

Acute Tox. 3

Skin Sens. 1

Aquatic Acute 1 Aquatic Chronic 1

H351

H331

H301

H317

H400

H410

GHS08

GHS06

GHS09

Dgr

H351

H331

H301

H317

H410

M = 10

M = 100

014-046-00-4

►C6  E-glasmicrovezels ◄ met een representatieve samenstelling; [Calcium-aluminium-silicaatvezels met willekeurige oriëntatie en de volgende representatieve samenstelling (in massapercentage): SiO2 50,0-56,0 %, Al2O3 13,0-16,0 %, B2O3 5,8-10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %. Proces: gewoonlijk met roterende vlamdemping. (Er kunnen nog andere elementen in kleine hoeveelheden aanwezig zijn; de procesbeschrijving sluit geen innovatie uit).]

—

—

Carc. 1B

H350i

GHS08

Dgr

H350i

A

014-047-00-X

►C6  Glasmicrovezels ◄ met een representatieve samenstelling; [Calcium-aluminium-silicaatvezels met willekeurige oriëntatie en de volgende samenstelling (in massapercentage): SiO2 55,0-60,0 %, Al2O3 4,0-7,0 %, B2O3 8,0-11,0 %, ZrO2 0,0-4,0 %, Na2O 9,5-13,5 %, K2O 0,0-4,0 %, CaO 1,0-5,0 %, MgO 0,0-2,0 %, Fe2O3 < 0,2 %, ZnO 2,0-5,0 %, BaO 3,0-6,0 %, F2 < 1,0 %. Proces: gewoonlijk met roterende vlamdemping. (Er kunnen nog andere elementen in kleine hoeveelheden aanwezig zijn; de procesbeschrijving sluit geen innovatie uit).]

—

—

Carc. 2

H351 (inademing)

GHS08

Wng

H351 (inademing)

A

047-003-00-3

zilverzinkzeoliet (zeoliet, type LTA, oppervlakte gewijzigd met zilver- en zinkionen)

[Deze rubriek betreft zeoliet van het type LTA (Linde-type A) waarvan de oppervlakte is gewijzigd met zowel zilver- als zinkionen met de gehalten Ag+ 0,5 % — 6 %, Zn2 + 5 % — 16 %, en eventueel met fosfor, NH4+, mg2+ en/of Ca2+, telkens < 3 %]

—

130328-20-0

Repr. 2

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H361d

H315

H318

H400

H410

GHS08

GHS05

GHS09

Dgr

H361d

H315

H318

H410

M = 100

M = 100

048-012-00-5

cadmiumcarbonaat

208-168-9

513-78-0

Carc. 1B

Muta. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H340

H332

H312

H302

H372 (nier, bot)

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H340

H332

H312

H302

H372 (nier, bot)

H410

A1

048-013-00-0

cadmiumhydroxide; cadmiumdihydroxide

244-168-5

21041-95-2

Carc. 1B

Muta. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H340

H332

H312

H302

H372 (nier, bot)

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H340

H332

H312

H302

H372 (nier, bot)

H410

A1

048-014-00-6

cadmiumnitraat;

cadmiumdinitraat

233-710-6

10325-94-7

Carc. 1B

Muta. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H340

H332

H312

H302

H372 (nier, bot)

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H340

H332

H312

H302

H372 (nier, bot)

H410

Carc. 1B; H350:

C ≥ 0,01 %

A1

050-030-00-3

dibutyltindilauraat; dibutyl[bis(dodecanoyloxy)]stannaan

201-039-8

77-58-7

Muta. 2

Repr. 1B

STOT RE 1

H341

H360FD

H372 (immuunsysteem)

GHS08

Dgr

H341

H360FD

H372 (immuunsysteem)

602-020-00-0

1,2-dichloorpropaan;

propyleendichloride

201-152-2

78-87-5

Flam. Liq. 2

Carc. 1B

Acute Tox. 4*

Acute Tox. 4*

H225

H350

H332

H302

GHS02

GHS08

GHS07

Dgr

H225

H350

H332

H302

602-033-00-1

chloorbenzeen

203-628-5

108-90-7

Flam. Liq. 3

Acute Tox. 4

Skin Irrit. 2

Aquatic Chronic 2

H226

H332

H315

H411

GHS02

GHS07

GHS09

Wng

H226

H332

H315

H411

603-055-00-4

propyleenoxide;

1,2-epoxypropaan; methyloxiraan

200-879-2

75-56-9

Flam. Liq. 1

Carc. 1B

Muta. 1B

Acute Tox. 3

Acute Tox. 3

Acute Tox. 4

STOT SE 3

Eye Irrit. 2

H224

H350

H340

H331

H311

H302

H335

H319

GHS02

GHS08

GHS06

Dgr

H224

H350

H340

H331

H311

H302

H335

H319

603-235-00-2

linalool; 3,7-dimethyl-1,6-octadieen-3-ol; dl-linalool; [1]

coriandrol; (S)-3,7-dimethyl-1,6-octadieen-3-ol; d-linalool; [2]

licareol; (R)-3,7-dimethyl-1,6-octadieen-3-ol; l-linalool [3]

201-134-4 [1]

204-810-7 [2]

204-811-2 [3]

78-70-6 [1]

126-90-9 [2]

126-91-0 [3]

Skin Sens. 1B

H317

GHS07

Wng

H317

604-057-00-8

reactiemassa van: isomeren van 2-(2H-benzotriazool-2-yl)-4-methyl-(n)-dodecylfenol; isomeren van 2-(2H-benzotriazool-2-yl)-4-methyl-(n)-tetracosylfenol; isomeren van 2-(2H-benzotriazool-2-yl)-4-methyl-5,6-didodecyl-fenol. n = 5 of 6

401-680-5

—

Aquatic Chronic 4

H413

H413

604-092-00-9

fenol, dodecyl-, vertakt; [1]

fenol, 2-dodecyl-, vertakt; [2]

fenol, 3-dodecyl-, vertakt; [3]

fenol, 4-dodecyl-, vertakt; [4]

fenol, (tetrapropenyl)-derivaten [5]

310-154-3 [1]

[2]

[3]

[4]

[5]

121158-58-5 [1]

[2]

[3]

210555-94-5 [4]

74499-35-7 [5]

Repr. 1B

Skin Corr. 1C

Eye Dam. 1

Aquatic Acute 1 Aquatic Chronic 1

H360F

H314

H318

H400

H410

GHS08

GHS05

GHS09

Dgr

H360F

H314

H410

M = 10

M = 10

604-093-00-4

chlorofeen;

2-benzyl-4-chloorfenol

204-385-8

120-32-1

Carc. 2

Repr. 2

Acute Tox. 4

Skin Irrit. 2

Skin Sens. 1

Eye Dam. 1

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H361f

H332

H315

H317

H318

H373 (nier)

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H351

H361f

H332

H315

H317

H318

H373 (nier)

H410

M = 1

M = 100

605-013-00-0

chloralose (INN);

(R)-1,2-O-(2,2,2-trichloroethylideen)-α-D-glucofuranose; glucochloralose; anhydroglucochloral

240-016-7

15879-93-3

Acute Tox. 4*

Acute Tox. 3

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H332

H301

H336

H400

H410

GHS06

GHS09

Dgr

H332

H301

H336

H410

M = 10

M = 10

C

605-022-00-X

glutaral; glutaaraldehyde;

1,5-pentanedial

203-856-5

111-30-8

Acute Tox. 2

Acute Tox. 3

STOT SE 3

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 2

H330

H301

H335

H314

H334

H317

H400

H411

GHS06

GHS05

GHS08

GHS09

Dgr

H330

H301

H335

H314

H334

H317

H410

EUH071

STOT SE 3; H335: 0,5 % ≤ C < 5 %

M = 1

605-023-00-5

5-chloor-2-(4-chloorfenoxy)fenol;

[DCPP]

429-290-0

3380-30-1

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

M = 10

M = 10

605-040-00-8

hydroxyisohexyl 3-cyclohexeen carboxaldehyde (INCI); reactiemassa van 4-(4-hydroxy-4-methylpentyl)cyclohex-3-een-1-carbaldehyde en 3-(4-hydroxy-4-methylpentyl)cyclohex-3-een-1-carbaldehyde; [1]

4-(4-hydroxy-4-methylpentyl)cyclohex-3-een-1-carbaldehyde; [2]

3-(4-hydroxy-4-methylpentyl)cyclohex-3-een-1-carbaldehyde [3]

- [1]

250-863-4 [2]

257-187-9 [3]

130066-44-3 [1]

31906-04-4 [2]

51414-25-6 [3]

Skin Sens. 1A

H317

GHS07

Wng

H317

606-014-00-9

chloorfacinon (ISO);

2-[(4-chloorfenyl)(fenyl)acetyl]-1H-indan-1,3(2H)-dion

223-003-0

3691-35-8

Repr. 1B

Acute Tox. 1

Acute Tox. 1

Acute Tox. 1

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H360D

H330

H310

H300

H372 (bloed)

H400

H410

GHS08

GHS06

GHS09

Dgr

H360D

H330

H310

H300

H372 (bloed)

H410

Repr. 1B; H360D:

C ≥ 0,003 %

STOT RE 1; H372 (bloed): C ≥ 0,1 %

STOT RE 2; H373 (bloed):

0,01 % ≤ C < 0,1 %

M = 1

M = 1

606-021-00-7

N-methyl-2-pyrrolidon; 1-methyl-2-pyrrolidon

212-828-1

872-50-4

Repr. 1B

STOT SE 3

Skin Irrit. 2

Eye Irrit. 2

H360D***

H335

H315

H319

GHS08

GHS07

Dgr

H360D***

H335

H315

H319

STOT SE 3; H335: C ≥ 10 %

606-041-00-6

2-methyl-1-(4-methylthiofenyl)-2-morfolinopropaan-1-on

400-600-6

71868-10-5

Repr. 1B

Acute Tox. 4 *

Aquatic Chronic 2

H360FD

H302

H411

GHS08

GHS07

GHS09

Dgr

H360FD

H302

H411

606-150-00-9

clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-chloorallyloxyimino]propyl}-5-[(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-on

—

99129-21-2

Acute Tox. 4

Skin Sens. 1

Aquatic Chronic 3

H302

H317

H412

GHS07

Wng

H302

H317

H412

EUH066

606-151-00-4

antrachinon

201-549-0

84-65-1

Carc. 1B

H350

GHS08

Dgr

H350

607-056-00-0

warfarine (ISO);

4-hydroxy-3-(3-oxo-1-fenylbutyl)-2H-chromeen-2-on; [1]

(S)-4-hydroxy-3-(3-oxo-1- fenylbutyl)-2-benzopyron; [2]

(R)-4-hydroxy-3-(3-oxo-1-fenylbutyl)-2-benzopyron [3]

201-377-6

[1]

226-907-3

[2]

226-908-9

[3]

81-81-2 [1]

5543-57-7

[2]

5543-58-8

[3]

Repr. 1A

Acute Tox. 1

Acute Tox. 1

Acute Tox. 2

STOT RE 1

Aquatic Chronic 2

H360D

H330

H310

H300

H372 (bloed)

H411

GHS08

GHS06

GHS09

Dgr

H360D

H330

H310

H300

H372 (bloed)

H411

Repr. 1A; H360D:

C ≥ 0,003 %

STOT RE 1; H372 (bloed): C ≥ 0,5 %

STOT RE 2; H373 (bloed): 0,05 % ≤ C < 0,5 %

607-059-00-7

cumatetralyl (ISO); 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naftyl)cumarine

227-424-0

5836-29-3

Repr. 1B

Acute Tox. 2

Acute Tox. 3

Acute Tox. 2

STOT RE 1

Aquatic Chronic 1

H360D

H330

H311

H300

H372 (bloed)

H410

GHS08

GHS06

GHS09

Dgr

H360D

H330

H311

H300

H372 (bloed)

H410

Repr. 1B; H360D: C ≥ 0,003 %

STOT RE 1; H372 (bloed): C ≥ 1,0 %

STOT RE 2; H373 (bloed) 0,1 % ≤ C < 1,0 %

M = 10

607-123-00-4

2,3-epoxypropylmethacrylaat;

glycidylmethacrylaat

203-441-9

106-91-2

Carc. 1B

Muta. 2

Repr. 1B

Acute Tox. 3

Acute Tox. 4

STOT SE 3

STOT RE 1

Eye Dam. 1

Skin Corr. 1C

Skin Sens. 1

H350

H341

H360F

H311

H302

H335

H372 (luchtwegen) (inademing)

H318

H314

H317

GHS08

GHS06

GHS05

Dgr

H350

H341

H360F

H311

H302

H335

H372 (luchtwegen) (inademing)

H314

H317

D

607-157-00-X

difenacum (ISO); 3-(3-bifenyl-4-yl-1,2,3,4-tetrahydro-1-naftyl)-4-hydroxycumarine

259-978-4

56073-07-5

Repr. 1B

Acute Tox. 1

Acute Tox. 1

Acute Tox. 1

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H360D

H330

H310

H300

H372 (bloed)

H400

H410

GHS08

GHS06

GHS09

Dgr

H360D

H330

H310

H300

H372 (bloed)

H410

Repr. 1B; H360D:

C ≥ 0,003 %

STOT RE 1; H372 (bloed): C ≥ 0,02 % STOT RE 2; H373 (bloed):

0,002 % ≤ C < 0,02 %

M = 10

M = 10

607-172-00-1

brodifacoum (ISO);

4-hydroxy-3-(3-(4′ -broom-4-bifenylyl)-1,2,3,4-tetrahydro-1-naftyl)cumarine

259-980-5

56073-10-0

Repr. 1A

Acute Tox. 1

Acute Tox. 1

Acute Tox. 1

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H360D

H330

H310

H300

H372 (bloed)

H400

H410

GHS08

GHS06

GHS09

Dgr

H360D

H330

H310

H300

H372 (bloed)

H410

Repr. 1A; H360D:

C ≥ 0,003 %

STOT RE 1; H372 (bloed): C ≥ 0,02 % STOT RE 2; H373 (bloed):

0,002 % ≤ C < 0,02 %

M = 10

M = 10

607-375-00-5

flocumafen (ISO); reactiemassa van: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormethylbenzyloxy)fenyl)-1-naftyl)cumarine en trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormethylbenzyloxy)fenyl)-1-naftyl)cumarine

421-960-0

90035-08-8

Repr. 1B

Acute Tox. 1

Acute Tox. 1

Acute Tox. 1

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H360D

H330

H310

H300

H372 (bloed)

H400

H410

GHS08

GHS06

GHS09

Dgr

H360D

H330

H310

H300

H372 (bloed)

H410

Repr. 1B; H360D:

C ≥ 0,003 %

STOT RE 1; H372 (bloed): C ≥ 0,05 %

STOT RE 2; H373 (bloed):

0,005 % ≤ C < 0,05 %

M = 10

M = 10

607-623-00-2

diisobutylftalaat

201-553-2

84-69-5

Repr. 1B

H360Df

GHS08

Dgr

H360Df

607-716-00-8

bromadiolon (ISO); 3-[3-(4′ -broombifenyl-4-yl)-3-hydroxy-1-fenylpropyl]-4-hydroxy-2H-chromeen-2-on

249-205-9

28772-56-7

Repr. 1B

Acute Tox. 1

Acute Tox. 1

Acute Tox. 1

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H360D

H330

H310

H300

H372 (bloed)

H400

H410

GHS08

GHS06

GHS09

Dgr

H360D

H330

H310

H300

H372 (bloed)

H410

Repr. 1B; H360D:

C ≥ 0,003 %

STOT RE 1; H372 (bloed): C ≥ 0,005 % STOT RE 2; H373 (bloed):

0,0005 % ≤ C < 0,005 %

M = 1

M = 1

607-717-00-3

difethialon (ISO);

3-[3-(4′ -broombifenyl-4-yl)-1,2,3,4-tetrahydronaftaleen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-on

—

104653-34-1

Repr. 1B

Acute Tox. 1

Acute Tox. 1

Acute Tox. 1

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H360D

H330

H310

H300

H372 (bloed)

H400

H410

GHS08

GHS06

GHS09

Dgr

H360D

H330

H310

H300

H372 (bloed)

H410

EUH070

Repr. 1B; H360D:

C ≥ 0,003 %

STOT RE 1; H372 (bloed): C ≥ 0,02 % STOT RE 2; H373 (bloed):

0,002 % ≤ C < 0,02 %

M = 100

M = 100

607-718-00-9

perfluorononaan-1 zuur [1] en de natrium- [2] en ammoniumzouten [3] daarvan

206-801-3 [1]

[2]

[3]

375-95-1 [1]

21049-39-8 [2]

4149-60-4 [3]

Carc. 2

Repr. 1B

Lact.

Acute Tox. 4

Acute Tox. 4

STOT RE 1

Eye Dam. 1

H351

H360Df

H362

H332

H302

H372 (lever, thymus, milt)

H318

GSH08

GSH07

GHS05

Dgr

H351

H360Df

H362

H332

H302

H372 (lever, thymus, milt)

H318

607-719-00-4

dicyclohexylftalaat

201-545-9

84-61-7

Repr. 1B

Skin Sens. 1

H360D

H317

GHS08

GHS07

Dgr

H360D

H317

607-720-00-X

nonadecafluordecaanzuur; [1]

ammoniumnonadecafluordecanoaat; [2]

natriumnonadecafluordecanoaat [3]

206-400-3 [1] 221-470-5 [2]

[3]

335-76-2 [1] 3108-42-7 [2]

3830-45-3 [3]

Carc. 2

Repr. 1B

Lact.

H351

H360Df

H362

GHS08

Dgr

H351

H360Df

H362

607-721-00-5

N,N′-methyleendimorfoline;

N,N′-methyleenbismorfoline;

[uit N,N′-methyleenbismorfoline vrijkomende formaldehyde];

[MBM]

227-062-3

5625-90-1

Carc. 1B

Muta. 2

Acute Tox. 4

Acute Tox. 4

Acute Tox. 4

STOT RE 2

Skin Corr. 1B

Skin Sens. 1

Eye Dam. 1

H350

H341

H332

H312

H302

H373 (spijsverteringskanaal, luchtwegen)

H314

H317

H318

GHS08

GHS07

GHS05

Dgr

H350

H341

H332

H312

H302

H373 (spijsverteringskanaal, luchtwegen)

H314

H317

EUH071

8

9

607-722-00-0

2,3,5,6-tetrafluor-4-(methoxymethyl)benzyl-(Z)-(1R,3R)-3-(2-cyaanprop-1-enyl)-2,2-dimethylcyclopropaan-carboxylaat;

epsilon-momfluorothrine

—

1065124-65-3

Acute Tox. 4

STOT SE 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H371 (zenuwstelsel)

H400

H410

GHS07

GHS08

GHS09

Wng

H302

H371 (zenuwstelsel)

H410

M = 100

M = 100

607-723-00-6

tefluthrin (ISO);

2,3,5,6-tetrafluor-4-methylbenzyl-(1RS,3RS)-3-[(Z)-2-chloor-3,3,3-trifluorprop-1-enyl]-2,2-dimethylcyclopropaan-carboxylaat

—

79538-32-2

Acute Tox. 1

Acute Tox. 2

Acute Tox. 2

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H400

H410

GHS06

GHS09

Dgr

H330

H310

H300

H410

M = 10 000

M = 10 000

608-055-00-8

fipronil (ISO);

(±)-5-amino-1-(2,6-dichloor-α,α,α-trifluor-para-tolyl)-4-trifluormethylsulfinyl-pyrazool-3-carbonitril

424-610-5

120068-37-3

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H311

H331

H372 *

H400

H410

GHS06

GHS08

GHS09

Dgr

H301

H311

H331

H372 *

H410

M = 1 000

M = 10 000

608-067-00-3

3,7-dimethylocta-2,6-dieennitril

225-918-0

5146-66-7

Muta. 1B

H340

GHS08

Dgr

H340

612-150-00-X

spiroxamine (ISO);

8-tert-butyl-1,4-dioxaspiro[4.5]decaan-2-ylmethyl(ethyl)(propyl)amine

—

118134-30-8

Repr. 2

Acute Tox. 4

Acute Tox. 4

Acute Tox. 4

STOT RE 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361d

H332

H312

H302

H373 (oog)

H315

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361d

H332

H312

H302

H373 (oog)

H315

H317

H410

M = 100

M = 100

612-288-00-0

bupirimaat (ISO);

5-butyl-2-ethylamino-6-methylpyrimidin-4-yl dimethylsulfamaat

255-391-2

41483-43-6

Carc. 2

Skin Sens. 1B

Aquatic Chronic 1

H351

H317

H410

GHS08

GHS07

GHS09

Wng

H351

H317

H410

M = 1

612-289-00-6

triflumizol (ISO);

(1E)-N-[4-chloor-2-(trifluormethyl)fenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimine

—

68694-11-1

Repr. 1B

Acute Tox. 4

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H360D

H302

H373 (lever)

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H360D

H302

H373 (lever)

H317

H410

M = 1

M = 1

612-290-00-1

reactieproducten van paraformaldehyde en 2-hydroxypropylamine (verhouding 3:2);

[uit 3,3′-methyleenbis[5-methyloxazolidine] vrijkomende formaldehyde;

uit oxazolidine vrijkomende formaldehyde];

[MBO]

—

—

Carc. 1B

Muta. 2

Acute Tox. 4

Acute Tox. 3

Acute Tox. 4

STOT RE 2

Skin Corr. 1B

Eye Dam. 1

Skin Sens. 1A

Aquatic Chronic 2

H350

H341

H332

H311

H302

H373 (spijsverteringskanaal, luchtwegen)

H314

H318

H317

H411

GHS08

GHS06

GHS05

GHS09

Dgr

H350

H341

H332

H311

H302

H373 (spijsverteringskanaal, luchtwegen)

H314

H317

H411

EUH071

8

9

612-291-00-7

reactieproducten van paraformaldehyde met 2-hydroxypropylamine (verhouding 1:1);

[uit α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol vrijkomende formaldehyde];

[HPT]

—

—

Carc. 1B

Muta. 2

Acute Tox. 4

Acute Tox. 4

STOT RE 2

Skin Corr. 1C

Eye Dam. 1

Skin Sens. 1A

Aquatic Chronic 2

H350

H341

H332

H302

H373 (spijsverteringskanaal, luchtwegen)

H314

H318

H317

H411

GHS08

GHS07

GHS05

GHS09

Dgr

H350

H341

H332

H302

H373 (spijsverteringskanaal, luchtwegen)

H314

H317

H411

EUH071

8

9

612-292-00-2

methylhydrazine

200-471-4

60-34-4

Carc. 1B

H350

GHS08

Dgr

H350

613-121-00-4

chloorsulfuron (ISO); 2-chloor-N-[[(4-methoxy-6-methyl-1,3,5-triazine-2- yl)amino]carbonyl]benzeensulfonamide

265-268-5

64902-72-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1 000

M = 100

613-318-00-5

fenpyrazamine (ISO);

S-allyl-5-amino-2,3-dihydro-2-isopropyl-3-oxo-4-(o-tolyl)pyrazool-1-carbothioaat;

S-allyl-5-amino-2-isopropyl-4-(2-methylfenyl)-3-oxo-2,3-dihydropyrazool-1-carbothioaat

—

473798-59-3

Aquatic Acute 1 Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 10

M = 1

613-321-00-1

(RS)-4-[1-(2,3-dimethylfenyl)ethyl]-1H-imidazool;

medetomidine

—

86347-14-0

Acute Tox. 2

Acute Tox. 2

STOT SE 3

STOT SE 1

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H300

H336

H370 (oog)

H372

H400

H410

GHS06

GHS08

GHS09

Dgr

H330

H300

H336

H370 (oog)

H372

H410

M = 1

M = 100

613-322-00-7

triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chloorfenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazool-1-yl)butaan-2-ol;

α-tert-butyl-β-(4-chloorfenoxy)-1H-1,2,4-triazool-1-ethanol

259-537-6

55219-65-3

Repr. 1B

Lact.

Acute Tox. 4

Aquatic Chronic 2

H360

H362

H302

H411

GHS08

GHS07

GHS09

Dgr

H360

H362

H302

H411

613-323-00-2

terbutylazine (ISO);

N-tert-butyl-6-chloor-N′-ethyl-1,3,5-triazine-2,4-diamine

227-637-9

5915-41-3

Acute Tox. 4

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H373

H400

H410

GHS07

GHS08

GHS09

Wng

H302

H373

H410

M = 10

M = 10

613-324-00-8

chinoline-8-ol;

8-hydroxychinoline

205-711-1

148-24-3

Repr. 1B

Acute Tox. 3

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H360D

H301

H318

H317

H400

H410

GHS08

GHS06

GHS05

GHS09

Dgr

H360D

H301

H318

H317

H410

M = 1

M = 1

613-325-00-3

thiacloprid (ISO);

(Z)-3-(6-chloor-3-pyridylmethyl)-1,3-thiazolidine-2-ylideencyaanamide;

{(2Z)-3-[(6-chloorpyridine-3-yl)methyl]-1,3-thiazolidine-2-ylideen}cyaanamide

—

111988-49-9

Carc. 2

Repr. 1B

Acute Tox. 4

Acute Tox. 3

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H351

H360FD

H332

H301

H336

H400

H410

GHS08 GHS06

GHS09

Dgr

H351

H360FD

H332

H301

H336

H410

M = 100

M = 100

615-013-00-2

cyaanamide;

carbanonitril

206-992-3

420-04-2

Carc. 2

Repr. 2

Acute Tox. 3

Acute Tox. 3

STOT RE 2

Skin Corr. 1

Skin Sens. 1

Eye Dam. 1

Aquatic Chronic 3

H351

H361fd

H311

H301

H373 (schildklier)

H314

H317

H318

H412

GHS08

GHS06

GHS05

Dgr

H351

H361fd

H311

H301

H373 (schildklier)

H314

H317

H412

616-006-00-7

dichlofluanide (ISO);

N-[(dichloorfluormethyl)thio]-N′,N′-dimethyl-N-fenylsulfamide

214-118-7

1085-98-9

Acute Tox. 4

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H332

H319

H317

H400

GHS07

GHS09

Wng

H332

H319

H317

H400

M = 10

616-011-00-4

N,N-dimethylacetamide

204-826-4

127-19-5

Repr. 1B

Acute Tox. 4*

Acute Tox. 4*

H360D***

H332

H312

GHS08

GHS07

Dgr

H360D***

H332

H312

616-037-00-6

acetochloor (ISO); 2-chloor-N-(ethoxymethyl)-N-(2-ethyl-6-methylfenyl)acetamide

251-899-3

34256-82-1

Carc. 2

Repr. 2

Acute Tox. 4

STOT SE 3

STOT RE 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H361f

H332

H335

H373 (nier)

H315

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361f

H332

H335

H373 (nier)

H315

H317

H410

M = 1 000

M = 100

616-094-00-7

3,3′-dicyclohexyl-1,1′-methyleenbis(4,1-fenyleen)diureum

406-370-3

58890-25-8

Aquatic Chronic 4

H413

H413

616-207-00-X

polyhexamethyleenbiguanide hydrochloride;

PHMB

—

32289-58-0

27083-27-8

Carc. 2

Acute Tox. 2

Acute Tox. 4

STOT RE 1

Eye Dam. 1

Skin Sens. 1B

Aquatic Acute 1

Aquatic Chronic 1

H351

H330

H302

H372 (luchtwegen) (inademing)

H318

H317

H400

H410

GHS08

GHS06

GHS05

GHS09

Dgr

H351

H330

H302

H372 (luchtwegen) (inademing)

H318

H317

H410

M = 10

M = 10

616-218-00-X

benzovindiflupyr (ISO); N-[9-(dichloormethyleen)-1,2,3,4-tetrahydro-1,4-methaannaftaleen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazool-4-carboxamide

—

1072957-71-1

Acute Tox. 3

Acute Tox. 3

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H400

H410

GHS06

GHS09

Dgr

H331

H301

H410

M = 100

M = 100

616-219-00-5

fluopyram (ISO); N-{2-[3-chloor-5-(trifluoromethyl)pyridine-2-yl]ethyl}-2-(trifluoromethyl)benzamide

—

658066-35-4

Aquatic Chronic 2

H411

GHS09

H411

616-220-00-0

pencycuron (ISO); 1-[(4-chloorfenyl)methyl]-1-cyclopentyl-3-fenylureum

266-096-3

66063-05-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1

616-221-00-6

hexaflumuron (ISO);

1-(3,5-dichloor-4-(1,1,2,2-tetrafluorethoxy)fenyl)-3-(2,6-difluorbenzoyl)ureum

401-400-1

86479-06-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1 000

M = 10 000

616-222-00-1

penthiopyrad (ISO);

(RS)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluormethyl)pyrazool-4-carboxamide

—

183675-82-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1

616-223-00-7

carbetamide (ISO);

(R)-1-(ethylcarbamoyl)ethyl-carbanilaat; (2R)-1-(ethylamino)-1-oxopropaan-2-yl-fenylcarbamaat

240-286-6

16118-49-3

Carc. 2

Repr. 1B

Acute Tox. 4

Aquatic Chronic 2

H351

H360D

H302

H411

GHS08

GHS07

GHS09

Dgr

H351

H360D

H302

H411

617-023-00-2

tert-butylhydroperoxide

200-915-7

75-91-2

Muta. 2

H341

GHS08

Wng

H341

650-032-00-X

cyproconazool (ISO); (2RS,3RS;2RS,3SR)-2-(4-chloorfenyl)-3-cyclopropyl-1-(1H-1,2,4-triazool-1-yl)butaan-2-ol

—

94361-06-5

Repr. 1B

Acute Tox. 3

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H360D

H301

H373 (lever)

H400

H410

GHS08

GHS06

GHS09

Dgr

H360D

H301

H373 (lever)

H410

M = 10

M = 1